Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating RO7566802 alone and in combination with atezolizumab in locally advanced, recurrent, or metastatic solid tumors (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Atezolizumab (atezolizumab)
• RO7566802

Snippet

Sponsor: Genentech, Inc. | Conditions: Locally Advanced Solid Tumors, Recurrent Solid Tumors | Phase 1 | Status: RECRUITING